The global cell separation market was valued at USD 9.08 billion in 2023 and it is predicted to surpass around USD 23.49 billion by 2033 with a CAGR of 9.97% from 2024 to 2033.
The cell separation market encompasses a diverse array of techniques and technologies aimed at isolating specific cell populations from complex mixtures. This process is fundamental in various applications, ranging from basic research to clinical diagnostics and personalized medicine. With a relentless pursuit of precision and efficiency, the market continues to witness notable growth and innovation.
The growth of the cell separation market is driven by an increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and infectious diseases has fueled the demand for advanced cell separation technologies to support diagnostic and therapeutic endeavors. Additionally, the rising adoption of cell-based therapies and regenerative medicine approaches has driven significant investment in research and development within the field. Moreover, technological advancements, including the development of high-throughput and automated systems, have enhanced the efficiency and scalability of cell separation processes, catering to the growing demands of the biotechnology and pharmaceutical industries.
In 2023, the consumables segment emerged as the dominant force in the market, capturing the largest revenue share at 62%. This segment's stronghold was primarily attributed to frequent purchases of consumables. Moreover, heightened investments in research and development by pharmaceutical and biopharmaceutical firms, particularly for the advancement of cutting-edge biologics like monoclonal antibodies and vaccines, propelled the growth of this segment.
Technological advancements in instruments are enabling more efficient cell separation in research, diagnostics, and therapeutic applications. Consequently, the instruments industry is poised for significant growth in the forecast period. Nonetheless, the high cost associated with instruments is projected to somewhat impede market expansion. To gain a competitive edge, companies are increasingly focusing on developing sustainable technologies. For example, in March 2022, Element Biosciences unveiled details about its upcoming Aviti DNA sequences.
In 2023, the animal cells segment claimed the largest revenue share, accounting for 54% of the market. This significant share was propelled by the increasing focus of governmental bodies, private enterprises, and healthcare institutions on the exploration and development of new drugs. Animal cells play a pivotal role in drug discovery and development processes, serving to evaluate the efficacy, pharmacokinetics, and initial toxicity of emerging drug compounds.
Meanwhile, the human cell segment is projected to demonstrate the most rapid growth rate, anticipated at 12.47% from 2024 to 2033. This surge is attributed to heightened attention towards human and cancer research, coupled with the diverse applications of isolated human cells in biopharmaceutical advancements, clinical trials, and scientific investigations. Additionally, favorable reimbursement policies associated with personalized medicine initiatives in developed nations are fostering increased demand for human cell isolation technologies.
In 2023, the centrifugation segment emerged as the market leader, commanding a substantial revenue share of 43%. This dominance can be attributed to the widespread adoption of centrifugation techniques across academic institutions, research laboratories, and the biotechnology and biopharmaceutical sectors. Centrifugation stands as a cornerstone process in various applications, with density gradient centrifugation and differential centrifugation emerging as the most commonly employed methods for cell isolation and separation.
Meanwhile, the surface marker technique is poised to experience the fastest growth rate, projected at 12.38% from 2024 to 2033. This notable expansion is fueled by increased investments in manufacturing infrastructure by industry players, coupled with advancements in product development. Manufacturers are actively leveraging advanced surface markers in their production processes to ensure enhanced quality of the final products.
In 2023, the biomolecule isolation segment emerged as the market leader, commanding a significant share of 30%. This segment exhibited robust growth momentum and is expected to maintain its position as the fastest-growing segment, with a projected compound annual growth rate (CAGR) of 11.44% from 2024 to 2033. The predominant factor driving its prominence is the increasing emphasis on the production of biopharmaceuticals, including biosimilars, monoclonal antibodies, and recombinant proteins. Moreover, heightened government funding for new drug development initiatives further propels market expansion.
Concurrently, the cancer research segment is forecasted to experience lucrative growth, with a projected CAGR of 10.17% from 2024 to 2033. This growth can be attributed to rising investments in cell-based research by both companies and research laboratories. Several public-private partnerships are channeling substantial investments into cancer research, driven by the escalating global incidence of cancer, thereby stimulating demand for innovative cell separation solutions.
In 2023, the segment comprising biotechnology and biopharmaceutical companies emerged as the market leader, capturing a significant revenue share of 43%. This segment is poised to maintain its dominance throughout the study period. These companies are deeply engaged in extensive research and development (R&D) endeavors aimed at pioneering new-generation therapeutics, which necessitate the utilization of advanced cell separation techniques. Additionally, the escalating research activities undertaken by commercial entities to develop efficient vaccines and therapeutics for COVID-19 are anticipated to fuel substantial demand for cell separation solutions, thereby fostering continued growth within this segment.
Meanwhile, the segment encompassing research laboratories and institutes is forecasted to demonstrate steady growth, with an estimated compound annual growth rate (CAGR) of 9.28% from 2024 to 2033. This growth trajectory can be attributed to the increasing R&D initiatives spearheaded by research institutions, particularly in the fields of oncology and neuroscience, aimed at the development of novel therapies. Furthermore, the proliferation of research institutes and laboratories worldwide is expected to serve as a key driver of segment expansion. For instance, in April 2022, Curate Biosciences forged a collaboration with the City of Hope, a prominent cancer research and treatment organization in the U.S., to evaluate the efficacy of its Curate Cell Processing System.
In 2023, North America emerged as the dominant force in the global market, commanding the largest revenue share at 40%. This prominence can be attributed to several factors, including the presence of well-established pharmaceutical and biotechnology industries, particularly in the United States. The region also exhibits a high adoption rate of technologically advanced solutions, further bolstering its market position. Moreover, the extensive research activities conducted by research universities in North America, particularly in the field of cell therapies, have spurred significant demand for cell separation solutions.
Conversely, Asia Pacific is forecasted to experience the fastest growth, with a projected growth rate of 15.66% from 2024 to 2033. This rapid expansion is driven by the burgeoning pharmaceutical and biotechnology industries in emerging economies such as China and India. Additionally, the region's growth is fueled by increased healthcare expenditure and the expanding market penetration of major global players in key Asia Pacific countries. Furthermore, ongoing initiatives in stem cell and gene therapy research in countries like Japan, China, and South Korea have further propelled the demand for cell separation solutions in the region.
By Product
By Cell Type
By Technique
By Application
By End-Use
By Region
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cell Separation Market
5.1. COVID-19 Landscape: Cell Separation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cell Separation Market, By Product
8.1. Cell Separation Market, by Product, 2024-2033
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Cell Separation Market, By Cell Type
9.1. Cell Separation Market, by Cell Type, 2024-2033
9.1.1. Human Cells
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Animal Cells
9.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Cell Separation Market, By Technique
10.1. Cell Separation Market, by Technique, 2024-2033
10.1.1. Centrifugation
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Surface Marker
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Filtration
10.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Cell Separation Market, By Application
11.1. Cell Separation Market, by Application, 2024-2033
11.1.1. Biomolecule Isolation
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Cancer Research
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Stem Cell Research
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Tissue Regeneration
11.1.4.1. Market Revenue and Forecast (2021-2033)
11.1.5. In Vitro Diagnostics
11.1.5.1. Market Revenue and Forecast (2021-2033)
11.1.6. Therapeutics
11.1.6.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Cell Separation Market, By End-Use
12.1. Cell Separation Market, by End-Use, 2024-2033
12.1.1. Research laboratories and institutes
12.1.1.1. Market Revenue and Forecast (2021-2033)
12.1.2. Biotechnology and biopharmaceutical companies
12.1.2.1. Market Revenue and Forecast (2021-2033)
12.1.3. Hospitals and diagnostic laboratories
12.1.3.1. Market Revenue and Forecast (2021-2033)
12.1.4. Cell banks
12.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 13. Global Cell Separation Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.1.3. Market Revenue and Forecast, by Technique (2021-2033)
13.1.4. Market Revenue and Forecast, by Application (2021-2033)
13.1.5. Market Revenue and Forecast, by End-Use (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.6.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.1.6.3. Market Revenue and Forecast, by Technique (2021-2033)
13.1.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.1.7. Market Revenue and Forecast, by End-Use (2021-2033)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.1.8.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.1.8.3. Market Revenue and Forecast, by Technique (2021-2033)
13.1.8.4. Market Revenue and Forecast, by Application (2021-2033)
13.1.8.5. Market Revenue and Forecast, by End-Use (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.2.3. Market Revenue and Forecast, by Technique (2021-2033)
13.2.4. Market Revenue and Forecast, by Application (2021-2033)
13.2.5. Market Revenue and Forecast, by End-Use (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.6.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.2.6.3. Market Revenue and Forecast, by Technique (2021-2033)
13.2.7. Market Revenue and Forecast, by Application (2021-2033)
13.2.8. Market Revenue and Forecast, by End-Use (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.9.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.2.9.3. Market Revenue and Forecast, by Technique (2021-2033)
13.2.10. Market Revenue and Forecast, by Application (2021-2033)
13.2.11. Market Revenue and Forecast, by End-Use (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.12.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.2.12.3. Market Revenue and Forecast, by Technique (2021-2033)
13.2.12.4. Market Revenue and Forecast, by Application (2021-2033)
13.2.13. Market Revenue and Forecast, by End-Use (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2021-2033)
13.2.14.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.2.14.3. Market Revenue and Forecast, by Technique (2021-2033)
13.2.14.4. Market Revenue and Forecast, by Application (2021-2033)
13.2.15. Market Revenue and Forecast, by End-Use (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.3.3. Market Revenue and Forecast, by Technique (2021-2033)
13.3.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.5. Market Revenue and Forecast, by End-Use (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.6.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.3.6.3. Market Revenue and Forecast, by Technique (2021-2033)
13.3.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.7. Market Revenue and Forecast, by End-Use (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.8.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.3.8.3. Market Revenue and Forecast, by Technique (2021-2033)
13.3.8.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.9. Market Revenue and Forecast, by End-Use (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.10.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.3.10.3. Market Revenue and Forecast, by Technique (2021-2033)
13.3.10.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.10.5. Market Revenue and Forecast, by End-Use (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2021-2033)
13.3.11.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.3.11.3. Market Revenue and Forecast, by Technique (2021-2033)
13.3.11.4. Market Revenue and Forecast, by Application (2021-2033)
13.3.11.5. Market Revenue and Forecast, by End-Use (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.4.3. Market Revenue and Forecast, by Technique (2021-2033)
13.4.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.5. Market Revenue and Forecast, by End-Use (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.6.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.4.6.3. Market Revenue and Forecast, by Technique (2021-2033)
13.4.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.7. Market Revenue and Forecast, by End-Use (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.8.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.4.8.3. Market Revenue and Forecast, by Technique (2021-2033)
13.4.8.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.9. Market Revenue and Forecast, by End-Use (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.10.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.4.10.3. Market Revenue and Forecast, by Technique (2021-2033)
13.4.10.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.10.5. Market Revenue and Forecast, by End-Use (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2021-2033)
13.4.11.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.4.11.3. Market Revenue and Forecast, by Technique (2021-2033)
13.4.11.4. Market Revenue and Forecast, by Application (2021-2033)
13.4.11.5. Market Revenue and Forecast, by End-Use (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.5.3. Market Revenue and Forecast, by Technique (2021-2033)
13.5.4. Market Revenue and Forecast, by Application (2021-2033)
13.5.5. Market Revenue and Forecast, by End-Use (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.6.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.5.6.3. Market Revenue and Forecast, by Technique (2021-2033)
13.5.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.5.7. Market Revenue and Forecast, by End-Use (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2021-2033)
13.5.8.2. Market Revenue and Forecast, by Cell Type (2021-2033)
13.5.8.3. Market Revenue and Forecast, by Technique (2021-2033)
13.5.8.4. Market Revenue and Forecast, by Application (2021-2033)
13.5.8.5. Market Revenue and Forecast, by End-Use (2021-2033)
Chapter 14. Company Profiles
14.1. Thermo Fisher Scientific, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. BD
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Danaher
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Terumo Corp.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. STEMCELL Technologies Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Bio-Rad Laboratories, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Merck KGaA
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Agilent Technologies, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Corning Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Akadeum Life Sciences
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms